Live Breaking News & Updates on Medanta Institute|Page 4

Stay updated with breaking news from Medanta institute. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Post-inoculation possibility: May be many breakthrough cases, but mild, says ICMR

Post-inoculation possibility: May be many breakthrough cases, but mild, says ICMR
SECTIONS
Share
Synopsis
Samiran Panda, head, epidemiology & infectious disease, ICMR said studies, although at initial stages, show that vaccines help reduce risk of hospitalisation significantly. It is possible that a large number of people who get infected are not going for testing because symptoms are mild. ICMR estimates breakthrough infection in India to be around 4.5% and has not recorded deaths post-vaccination.
PTI
Vaccines used in India have efficacy rates of 70-80% and experts say that means a large number of people can get infected post-vaccination.
India’s breakthrough infections the term for Covid-19 infections occurring in people after one or two doses of inoculation could be more than reported, but that does not mean vaccines are not working, said Samiran Panda, head, epidemiology & infectious disease, Indian Council of Medical Research (ICMR). ....

Arvinder Singh Soin , Anoop Misra , Medanta Institute Of Liver Transplantation , National Clinical Covid , Indian Council Of Medical Research , Us Center , Samiran Panda , Indian Council , Medical Research , National Clinical , Disease Control , Singh Soin , Medanta Institute , Liver Transplantation , Regenerative Medicine , Science Direct , Fortis Hospital , அரவிந்தர் சிங் மண் , அனூப் மிஸ்ரா , மேதாண்த நிறுவனம் ஆஃப் கல்லீரல் மாற்று அறுவை சிகிச்சை , இந்தியன் சபை ஆஃப் மருத்துவ ஆராய்ச்சி , எங்களுக்கு மையம் , இந்தியன் சபை , மருத்துவ ஆராய்ச்சி , தேசிய மருத்துவ , நோய் கட்டுப்பாடு ,

Rheumatoid arthritis drug improves outcomes in severely ill COVID-19 patients, finds new trial

Rheumatoid arthritis drug improves outcomes in severely ill COVID-19 patients, finds new trial
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.

City Of , United Kingdom , United States , Arvinder Soin , Emily Henderson , Medanta Liver Transplantation Institute , University Of Bristol School Clinical Sciences , Medanta Institute Of Education , University Of Bristol , Medanta Institute , Lancet Respiratory Medicine , Clinical Sciences , Consultant Paediatric Rheumatologist , Bristol Royal Hospital , Lead Co Author , North America , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , அரவிந்தர் மண் , எமிலி ஹென்டர்சன் , மேதாண்த கல்லீரல் மாற்று அறுவை சிகிச்சை நிறுவனம் , பல்கலைக்கழகம் ஆஃப் பிரிஸ்டல் பள்ளி மருத்துவ அறிவியல் , மேதாண்த நிறுவனம் ஆஃப் கல்வி , பல்கலைக்கழகம் ஆஃப் பிரிஸ்டல் , மேதாண்த நிறுவனம் ,

covid-19: Arthritis medicine effective in treating coronavirus - Covid-19: अर्थराइटिस की दवा कोरोना के इलाज में कारगर, शोध में हुआ दावा

covid-19: Arthritis medicine effective in treating coronavirus - Covid-19: अर्थराइटिस की दवा कोरोना के इलाज में कारगर, शोध में हुआ दावा
livehindustan.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from livehindustan.com Daily Mail and Mail on Sunday newspapers.

Medanta Institute , Education End Research , Lancet Respiratory Medicine , மேதாண்த நிறுவனம் ,

Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India

Date Time
Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across India – one of the world’s most ethnically diverse countries.
Researchers from the University of Bristol and Medanta Institute of Education and Research in India who led the study, published in The Lancet Respiratory Medicine, say it adds to existing evidence supporting the drug’s use in critically ill patients.
Conducted in 12 public and private hospitals across India, the COVID India Tocilizumab (COVINTOC) phase 3 randomised controlled trial aimed to investigate whether tocilizumab could prevent disease progression and mortality in hospitalised patients with moderate to severe COVID-19. ....

City Of , United Kingdom , United States , Arvinder Soin , Arvinders Soin , University Of Bristol Medical School , Medanta Institute Of Education , Medanta Liver Transplantation Institute At Gurugram , University Of Bristol , Medanta Institute , Lancet Respiratory Medicine , Medical School , Consultant Paediatric Rheumatologist , Bristol Royal Hospital , Medanta Liver Transplantation Institute , North America , Roche India , Cipla India , Lancet Respiratory , Rheumatoid Arthritis , Anti Inflammatory , Liver Transplant , Clinical Trials , Critically Ill , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் ,

Tocilizumab brings down fatality in severe COVID-19 patients

Tocilizumab brings down fatality in severe COVID-19 patients
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Madhya Pradesh , United Kingdom , Naresh Trehan , Dr Arvinder Soin National , Medanta Institute Of Education , Medanta Liver Institute , Lancet Respiratory , Managing Trustee , Medanta Institute , Managing Director , மத்யா பிரதேஷ் , ஒன்றுபட்டது கிஂக்டம் , னரேஷ் திர்ேன் , மேதாண்த நிறுவனம் ஆஃப் கல்வி , மேதாண்த கல்லீரல் நிறுவனம் , நிர்வகித்தல் அறங்காவலர் , மேதாண்த நிறுவனம் , நிர்வகித்தல் இயக்குனர் ,